Cardlytics, Inc. (CDLX) — Quarterly Report

Key Insights

• Cardlytics filed Q1 2026 10-Q on May 7, 2026, covering the period ending March 31, 2026, indicating timely regulatory compliance with SEC filing requirements.
• The filing shows multiple debt instruments including 2024 Convertible Senior Notes and revolving credit facilities, suggesting the company is managing a capital structure that includes both convertible debt and traditional credit lines.
• Presence of discontinued operations related to Bridg (noted in XBRL taxonomy) indicates prior divestitures or business unit separations that may impact year-over-year comparisons and operating performance analysis.
• The company maintains equity compensation programs including restricted stock units (RSUs) and performance shares with multiple vesting tranches, reflecting standard executive incentive structures for talent retention.
• Multiple references to international operations (GB country designation) suggest Cardlytics operates or has exposure outside the United States, introducing foreign exchange and regulatory complexity.